Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • Laboratory Analysis Indicates GlaxoSmithKline’s COVID-19 Therapy Effective Against Omicron Variant, Company Says

    Reuters (12/2, Burger) reports, “Laboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (GSK) is developing with U.S. partner Vir has indicated the drug is effective against the new Omicron variant, the British drugmaker said on Thursd...
    Full Article
  • Patients Who Receive Recombinant Zoster And Flu Vaccines Simultaneously Less Likely To Receive Flu Vaccine The Following Year, Study Indicates

    Drug Topics (12/2, Fox) reports, “Patients who receive the recombinant zoster and flu vaccines simultaneously were less likely to receive the flu vaccine the following year, according to study results.” The cohort study, published in JAMA Network Open, in...
    Full Article
  • EU Public Health Agency Warns Omicron Variant May Become Dominant In Europe Within A Few Months

    Reuters (12/2, Guarascio, Mason) reports the European Centre for Disease Prevention and Control “said on Thursday that the Omicron variant could be responsible for more than half of all COVID-19 infections in Europe within a few months, but no cases of se...
    Full Article
  • A Day in the Life with Nicole Jackson, MD

    Abstract Not Available
    Full Article
  • Detection of COVID-19 by Machine Learning Using Routine Laboratory Tests

    Abstract Not Available
    Full Article
  • First US Case Of Omicron Coronavirus Variant Identified In California

    The AP (12/1, Balsamo, Miller) reports, “A person in California who had been vaccinated against COVID-19 became the first in the U.S. to have an identified case of the omicron variant, the White House announced Wednesday as scientists continue to study th...
    Full Article
  • Researchers Model SARS-CoV-2 Transmission Though Aerosol Droplets

    The New York Times (12/1, Zimmer, Corum) reports, “To better understand the coronavirus’s journey from one person to another, a team of 50 scientists has for the first time created an atomic simulation of the coronavirus nestled in a tiny airborne drop of...
    Full Article
  • Inflammation Overrides Erythropoietic Signals In Determining Hepcidin Concentration In Patients With Tuberculosis, Research Indicates

    Hematology Advisor (12/1, Dembeck) reports research published in Blood indicates that “inflammation overrides erythropoietic signals in determining hepcidin concentration in patients with tuberculosis, and these patients also have negligible iron absorpti...
    Full Article
  • Both mRNA COVID-19 Vaccines Demonstrate High Effectiveness Against Infection, Study Indicates

    Healio (12/1, Miller) reports “both messenger RNA vaccines available in the U.S. demonstrated high effectiveness against COVID-19, although the Moderna vaccine was associated with a lower risk for infection and hospitalization than the Pfizer-BioNTech vac...
    Full Article
  • Patients Who Had Severe COVID-19 May Have Twice The Risk Of Dying Over Following Year, Study Suggests

    Fox News (12/1, McGorry) reports, “Patients who had severe COVID-19 may be twice at risk of dying over the following year, compared to patients who had a mild or moderate case, or individuals not infected by the novel coronavirus, according to a new study...
    Full Article
  • Adding Colchicine To Standard Care Regimen For COVID-19 Does Not Reduce Disease Severity, Risk For Death In Hospitalized Patients, Meta-Analysis Indicates

    Healio (11/30, Laday) reports, “Adding colchicine to the standard care regimen for COVID-19 fails to decrease disease severity or reduce the risk for death in hospitalized patients, according to a meta-analysis” that included “six randomized controlled st...
    Full Article
  • Omicron Coronavirus Variant Reportedly Has Changed How Some Health Experts See Need For Boosters

    The New York Times (12/1, A1, Mandavilli) reports the emergence of the Omicron coronavirus variant “has changed” how many public health experts view COVID-19 vaccine boosters, with “many of the experts who were opposed to boosters now believ[ing] that the...
    Full Article
  • In A First, WHO Approves Long-Acting Device To Protect Women From Sexually Transmitted HIV

    HealthDay (12/1, Preidt) reports “the World Health Organization (WHO) has approved the first long-acting device to protect women from sexually transmitted HIV.” HealthDay adds, “The device is a vaginal ring made of silicone elastomer, a flexible rubber-li...
    Full Article
  • Administration Unveils New HIV/AIDS Strategy Involving Greater Emphasis On Syringe Service Programs

    The AP (12/1, Madhani) reports that on Wednesday, President Biden “unveiled his new HIV/AIDS strategy to end the more than 40-year-old epidemic, calling for a renewed focus on vulnerable Americans – including gay and bisexual Black and Latino men, who his...
    Full Article
  • FDA Advisory Panel Recommends Emergency Authorization Of COVID-19 Antiviral

    The New York Times (11/30, Robbins, Zimmer) reports the FDA’s Antimicrobial Drugs Advisory Committee, “in a surprisingly narrow 13-to-10 vote, endorsed” Merck & Co.’s oral COVID-19 antiviral therapy molnupiravir, which now “could be authorized for use in...
    Full Article
  • US Improves Surveillance Of New Coronavirus Variants Following Slow Start

    The AP (11/30, Johnson) reports, “After a slow start, the United States has improved its surveillance system for tracking new coronavirus variants such as Omicron, boosting its capacity by tens of thousands of samples per week since early this year.” The...
    Full Article
  • CDC Expected To Tighten Testing Requirements For International Travel To US Amid Global Spread of Omicron COVID-19 Variant

    USA Today (11/30, Schulz) reports the CDC is aiming to tighten coronavirus testing requirements for international travelers in an effort “to combat the spread of the new Omicron COVID-19 variant.” ​​ The CDC “said Tuesday that it is ‘working to modify’ th...
    Full Article
  • Small Study Examines Clinical Characteristics, Molecular Genetics, Long-Term Follow-Up Of Patients With Neonatal Diabetes Mellitus

    HCPlive (11/30, Iopoce) reports researchers “set out to describe the clinical characteristics, molecular genetics, and long-term follow-up of 24 patients with” neonatal diabetes mellitus (NDM), “a rare form of monogenic diabetes,” from “a single pediatric...
    Full Article
  • Cold Plasma Ionized Gas Shows Early Efficacy In Eradicating Bacteria Commonly Found In Chronic Wounds, Research Indicates

    Medscape (11/30, A. Melville, Subscription Publication) reports, “A novel, antibiotic-free strategy for fighting antimicrobial-resistant bacteria using cold plasma ionized gas to activate key molecules has shown early efficacy in eradicating bacteria comm...
    Full Article
  • CDC Data Show Higher HIV Infection Rates Among Latino MSM, Only Slight Drop Among Black MSM

    USA Today (11/30, Miranda) reports new CDC data show “HIV infection rates in gay and bisexual Latino men increased from 6,800 new cases in 2010 to 7,900 new cases reported in 2019,” while “the number of new cases decreased only slightly from 9,000 in 2010...
    Full Article
  • «
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id